Investors in the most popular categories also often incurred an opportunity cost: Their funds tended to underperform other, ...

Berkshire Hathaway's board of directors has voted for Greg Abel to step in as chief executive on Jan. 1, 2026. Chief Executive Warren Buffett plans to remain as chairman of the board.

It's timely to review the Recession Buy Indicator after the report that the U.S. economy shrank at an annualized rate of 0.3% in the first quarter of this year. Many economists believe that President ...

Banco Santander agreed to sell most of its Polish assets to Austria's Erste Group Bank for 7 billion euros ($7.91 billion), continuing a wave of dealmaking among European lenders.

Berkshire Hathaway's board of directors has voted for Greg Abel to step in as chief executive on Jan. 1, 2026. Abel is currently Berkshire's vice chairman of non-insurance operations. Chief Executive ...

Speaking at Berkshire's annual meeting in Omaha, Buffett Says Greg Abel Should Succeed at Year-End. Three things combined to make Buffett, the stock-intoxicated man, an unrivaled investor.

ImmunityBio is seeking an urgent meeting with U.S. health regulators after its bladder-cancer treatment application was rejected. The immunotherapy company said Monday that it received a ...

My friend rebounded with a married woman after getting out of a long-term relationship. Initially, she said she was just married for money and either in an open marriage or separated, but the story ...

Most of Spain's new funds for defense will go to Spanish defense companies, the country's prime minister, Pedro Sanchez, said. The social democrat leader is set to present a new industrial and ...

Stock futures were lower, indicating markets could end a historic stretch of gains. Investors unhappy with Armistice's 19% loss in March can't leave anytime soon.

Speaking at an afternoon press conference, Yang sought to quash conjecture that the U.S. had asked Taiwan to boost the value of its currency. The central bank didn't participate in Taiwan-U.S. trade ...

Elanco Animal Health has sold royalty and milestone rights for Xdemvy's human health applications to Blackstone-affiliated funds for $295 million. The animal-medicine company said Monday that the ...